People: Anthera Pharmaceuticals Inc (ANTH.W)

ANTH.W on CBOE When Trading NASDAQ Global Select Market

0.55USD
7 May 2013
Price Change (% chg)

$-0.08 (-12.70%)
Prev Close
$0.63
Open
$0.55
Day's High
$0.55
Day's Low
$0.55
Volume
100
Avg. Vol
389
52-wk High
$3.08
52-wk Low
$0.51

Search Stocks

Lowe, Christopher 

Brief Biography

Mr. Christopher P. Lowe serves as Chief Financial Officer, Chief Business Officer of Anthera Pharmaceuticals Inc., since February 2011. Prior to that time and since November 2007, he served as Chief Financial Officer and Vice President of Administration. Beginning in September 2005 and up until he joined the company, Mr. Lowe served as Vice President of Finance & Administration and, beginning in January 2006, as Chief Financial Officer of Asthmatx, Inc., a medical technology company. Previously, Mr. Lowe was with Peninsula Pharmaceuticals, Inc., as Corporate Controller from June 2004 to October 2004 and Chief Accounting Officer from October 2004 until June 2005. Mr. Lowe holds a B.S. in business administration from California Polytechnic State University, San Luis Obispo and an M.B.A. from Saint Mary’s University, Texas. Mr. Lowe is a director of Hansen Medical Corporation, a medical device company.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
359,968 -- 583,124 943,092

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised 30,000 184,401.00
Name Fiscal Year Total

Christopher Henney

--

Paul Truex

1,486,080

Christopher Lowe

943,092

Debra Odink

622,372

Colin Hislop

936,716

Sanford Zweifach

--
As Of 30 Dec 2011
Search Stocks